New and future headache devices

Professor Alan Rapoport provides a holistic overview of new and upcoming devices for patients with headache. 



Alan M. Rapoport M.D. serves as an advisor for Allergan, Amgen, Biohaven, Cala Health, Novartis, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano; he is on the speaker bureau of Allergan, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries.